DEK and breast cancer: In this Ron receptor tyrosine kinase transgenic model, with wild-type or knockout Dek alleles, we discovered that Ron(tg)/Dek−/− mice were able to form mammary tumors but showed significantly delayed tumor initiation and fewer distant metastases when compared to Ron(tg)/Dek+/+ tumors [51].